YE

AR OF ESO

R

YE

AR OF ESO

R

myE

SR.o

rg/e

sor

Education in partnership

ASKLEPIOS Course

ADVANCED ONCOLOGIC IMAGINGSeptember 30 – October 1, 2016 Kazan/Russia

This ASKLEPIOS Course is implemented with great support and partnership of R-Pharm.

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

A

DVA

NC

ED

ON

CO

LOG

IC IM

AG

ING

ASKLEPIOS CourseADVANCED ONCOLOGIC IMAGINGSeptember 30 – October 1, 2016 Kazan/Russia

Course information

The course is designed for last year residents and recently board-certified radiologists. It is aimed at familiarising attendees from Russia and the CIS countries with recent advances and practices in oncologic imaging, as well as at creating an interest in subspecialisation related to the respective field of radiology. A multimodality imaging approach to a wide spectrum of neoplastic diseases, including head and neck, lung, liver, pancreas, small bowel, colon, prostate and pelvis is presented. The role of current imaging criteria and their limitations to assess treatment response of such tumours will be additionally reviewed. European experts in oncologic imaging ensure a high quality teaching programme combining lectures and interactive case discussions.

Learning objectives

• to present an update on current imaging protocols for the detection of some of the most frequent/important neoplastic diseases

• to learn more about the most important imaging features of such tumours and

• to understand the clinical relevance of imaging for patient management

• to explain the clinical significance of early tumour detection and the necessity for accurate staging, modern oncologic reporting for appropriate therapy planning and correct estimation prognosis

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

A

DVA

NC

ED

ON

CO

LOG

IC IM

AG

ING

For further information on the programme and registration please visit

Friday, September 30, 2016

08:00–08:45 Registration

08:45–09:00 Welcome and introduction

09:00–09:30 Multimodality imaging of laryngeal and oropharyngeal cancer N. Traikova, Plovdiv/BG

09:30–10:00 Multimodality imaging and staging of lung cancer I. Tyurin, Moscow/RU

10:00–10:30 CT/MR of HCC before, during and after treatment F. Caseiro Alves, Coimbra/PT

10:30–10:50 Coffee break

10:50–13:00 Workshops (N. Traikova, I. Tyurin, F. Caseiro Alves)

13:00–14:00 Lunch break

14:00–14:30 Solid pancreatic tumours: imaging protocols, staging, resectability

G. Karmazanovsky, Moscow/RU

14:30–15:00 Most common primary malignancies of the small intestine: challenges in depiction and characterisation using radiologic/pathologic correlations

N. Gourtsoyiannis, Athens/GR

15:00–15:30 Colorectal cancer: screening, diagnosis, staging A. Laghi, Latina/IT

15:30–15:50 Coffee break

15:50–18:00 Workshops (G. Karmazanovsky, N. Gourtsoyiannis, A. Laghi)

Saturday, October 1, 2016

09:00–09:30 MRI of prostate cancer N. Rubtsova, Moscow/RU

09:30–10:00 MR imaging of breast cancer before and after treatment M. Fuchsjäger, Graz/AT

10:00–10:30 Assessment of treatment response: current criteria and their limitations (RECIST and PERCIST)

M. Laniado, Dresden/DE

10:30–10:50 Coffee break

10:50–13:00 Workshops (N. Rubtsova, M. Fuchsjäger, M. Laniado)

13:00 Certificate of attendance

ProgrammeADVANCED ONCOLOGIC IMAGING

September 30 – October 1, 2016 Kazan/Russia

Host Organiser

I. TyurinMoscow/RU

VenueAdvanced Medical Technology

Education Center138, bld.9, Orenburgsky Trakt

420064 KazanRussia

RegistrationPlease visit myESR.org/esor for

registration information.

This ASKLEPIOS Course is implemented with great support and partnership of R-Pharm.

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

A

DVA

NC

ED

ON

CO

LOG

IC IM

AG

ING

ADVANCED ONCOLOGIC IMAGINGSeptember 30 – October 1, 2016 Kazan/Russia

Learning Objectives

Multimodality imaging of laryngeal and oropharyngeal cancerN. Traikova, Plovdiv/BG

• to learn the normal radiological anatomy of the larynx and oropharynx

• to become familiar with the most common neoplasms affecting oropharynx and larynx

• to recognise key imaging features of laryngeal and oropharyngeal cancer

• to understand the role of CT, MRI and PET in diagnosis, staging and management of laryngeal and oropharyngeal cancer

Multimodality imaging and staging of lung cancerI. Tyurin, Moscow/RU

• to review the current status of low dose CT screening of lung cancer

• to discuss the current recommendations for management of different types of small pulmonary nodules

• to describe the imaging features of different histological types of lung cancer

• to evaluate the new staging system for lung cancer and the significance of modern imaging modalities for tumour characterisation and staging

CT/MR of HCC before, during and after treatmentF. Caseiro Alves, Coimbra/PT

• to explain the steps of carcinogenesis and its impact on CT/MR imaging

• to learn the diagnostic criteria and current guidelines for patient management

• to discuss the role of functional imaging (perfusion and cell-directed contrast agents)

• to explain how to evaluate tumour response after minimally invasive therapy

Solid pancreatic tumours: imaging protocols, staging, resectabilityG. Karmazanovsky, Moscow/RU

• to review radiology of pancreatic ductal adenocarcinoma: diagnostic “gold standard” and new modalities for visualization and differentiation of pancreatic masses

• to understand staging and assessment of operability of pancreatic cancer

• to describe predictors of resectability of pancreatic tumours, vascular involvement and locally advanced pancreatic adenocarcinoma

• to estimate survival after operative resection and recurrence of pancreatic tumours

Most common primary malignancies of the small intestine: challenges in depiction and characterisation using radiologic/pathologic correlationsN. Gourtsoyiannis, Athens/GR

• to review epidemiology, clinical presentation and pathology of the most common primary malignancies of the small bowel, including adenocarcinoma, lymphoma and carcinoid

• to describe the imaging features of each of those neoplasms, using all applicable imaging modalities and discuss a differential diagnosis

• to provide a pathology-based understanding of the most important findings

This ASKLEPIOS Course is implemented with great support and partnership of R-Pharm.

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

A

DVA

NC

ED

ON

CO

LOG

IC IM

AG

ING

Learning ObjectivesADVANCED ONCOLOGIC IMAGING

September 30 – October 1, 2016 Kazan/Russia

Colorectal cancer: screening, diagnosis, stagingA. Laghi, Latina/IT

• to understand the potential role of imaging in colorectal cancer screening

• to learn the potentials of CT, PET-CT and MR in diagnosing and staging of colon cancer

• to understand the most effective diagnostic approach for rectal cancer staging

• to be aware of imaging biomarkers for the assessment of response to therapy in rectal cancer

MRI of prostate cancerN. Rubtsova, Moscow/RU

• to review radiology of prostate cancer: diagnosis and what the urologist needs, prostate anatomy (normal prostate and BPH)

• to become familiar with examination techniques and imaging protocols

• to learn staging and pitfalls of MRI of the prostate

• to understand mp-MRI and PI-RADS Version 2.0: how we do it

MR imaging of breast cancer before and after treatmentM. Fuchsjäger, Graz/AT

• to understand when and how to use MRI of the breast

• to consolidate knowledge on breast MRI interpretation based on the BI-RADS lexicon

• to understand common features related to breast surgery

• to recognise changes related to non-surgical treatments

Assessment of treatment response: current criteria and their limitations (RECIST and PERCIST)M. Laniado, Dresden/DE

• to review the concept of Response Evaluation Criteria in Solid Tumours (RECIST)

• to discuss the RECIST 1.1 criteria, which attempt to overcome limitations of pervious criteria

• to provide imaging examples of how RECIST criteria can be used

• to discuss the PERCIST criteria as an example of how recent advances in imaging techniques can be incorporated into tumour response evaluation

This ASKLEPIOS Course is implemented with great support and partnership of R-Pharm.

myE

SR.o

rg/e

sor

Please note that programmes are marked with a logo to indicate their classification according to the European Training Curriculum.

First three years of training

Fourth and fifth years of training (general radiologist standard)

Subspecialty training standard

ESOR stands for education in partnership.

This ASKLEPIOS Course is implemented with great support and partnership of R-Pharm.